rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Kyverna Therapeutics, Inc.

KYTX · Nasdaq

Health CareBiotechnologyNot moving yet

KYTX stood above a rising 150-day average in 33 of the last 52 weekly readings, and has been out of that trend for the last 15 weeks. It is 30.7% below that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 15
Industry in uptrend
15% -17 in 4 wk
Insider buys, 12 months
$2.0M
Insider sales, 12 months
$293K
Officials’ trades on record
0
Institutions holding
116 (+9)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 33 of 52 weeks.

17 Apr – 16 Oct
16%28%39%Apr 26Jun 26Jul 26Sep 26Oct 26

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
$0$1.9MNov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months2
Sale orders, 12 months1
Buyers · sellers2 · 1

No open-market buy or sale by its insiders on record.

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders116+9 on the quarter
New · exited31 · 21
Reported value$326.4M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
GordonMD Global Investments LPunchanged · filed 14 Aug 20264,244,818$37.8M00.0%
GILEAD SCIENCES, INC.unchanged · filed 3 Aug 20264,126,119$36.8M00.0%
BlackRock, Inc.added · filed 7 Aug 20263,134,807$27.9M+2,257,729+257.4%
Bain Capital Life Sciences Investors, LLCreduced · filed 14 Aug 20262,885,000$25.7M-225,000−7.2%
AIGH Capital Management LLCadded · filed 7 Aug 20262,795,797$24.9M+795,797+39.8%
DEERFIELD MANAGEMENT COMPANY, L.P.unchanged · filed 14 Aug 20262,000,000$17.8M00.0%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 20261,897,451$16.9M+114,109+6.4%
GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 20261,049,430$9.4M+625,604+147.6%
Insight Holdings Group, LLCunchanged · filed 14 Aug 2026989,054$8.8M00.0%
MORGAN STANLEYadded · filed 13 Aug 2026982,307$8.8M+5,018+0.5%
31 Mar 2024 – 30 Jun 2026
7595114Mar 24Sep 24Jun 25Dec 25Jun 26

Everyone who traded it

Beth C. Seidenberg Company insiderDirector · last 27 May 20261 · 0
Christi Shaw Company insiderExecutive Chairperson · last 27 May 20260 · 0
Fred E. Cohen Company insiderDirector · last 27 May 20260 · 0
Ian T. Clark Company insiderDirector · last 27 May 20260 · 0
Mert Aktar Company insiderDirector · last 27 May 20260 · 0
Gregory S. Martini Company insiderChief Financial Officer · last 18 May 20260 · 0
Nadia Dac Company insiderChief Commercial Officer · last 4 May 20260 · 0
Marc Grasso Company insiderChief Financial Officer · last 13 Mar 20260 · 0
Naji Gehchan Company insiderOfficer · last 13 Mar 20260 · 0
Warner Weston Biddle Company insiderChief Executive Officer · last 13 Mar 20260 · 0
Andrew Craig Miller Company insiderDirector · last 24 Feb 20260 · 0
Sravan Kumar Emany Company insiderDirector · last 24 Feb 20260 · 0

Same industry

MRNA ModernaLeading+147%
ENTX Entera BioLeading+37%
XNCR XencorLeading+30%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Return on capital employedFY 2025 · to 31 Dec 2025-66.0%
Share count trendFY 2025 · to 1 Mar 20260.1%
Cash and equivalentsFY 2025 · to 31 Dec 2025$124.1M
Free cash flowFY 2025 · to 31 Dec 2025−$153.7M

Analyst forecasts

No analyst forecasts yet.